Updated Jul 16, 2026
LeMaitre George W has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $44.98M.

George W. LeMaitre is the Chairman and CEO of LeMaitre Vascular Inc, a company specializing in medical devices for peripheral vascular disease. He has held various roles within the company, including Director, and has been instrumental in its growth and product development.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | LMAT | LEMAITRE VASCULAR INC | A — Grant or award | 12.0K | $0.00 | |
| 2026-06-05 | LMAT | LEMAITRE VASCULAR INC | G — Bona-fide gift | 12.0K | $0.00 | |
| 2026-05-11 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 27.9K | $108.69 | $3.03M |
| 2026-05-11 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale | 18.6K | $107.64 | $2.00M |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale [10b5-1] | 55.9K | $107.81 | $6.03M |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | G — Bona-fide gift [10b5-1] | 5.0K | $0.00 | |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture [10b5-1] | 496 | $113.69 | $56K |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise [10b5-1] | 13 | $0.00 | |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | A — Grant or award [10b5-1] | 5.6K | $0.00 | |
| 2026-03-03 | LMAT | LEMAITRE VASCULAR INC | S — Open-market sale [10b5-1] | 150.0K | $106.76 | $16.01M |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 681 | $82.93 | $56K |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 25 | $0.00 | |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 567 | $82.93 | $47K |
| 2025-12-11 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 21 | $0.00 | |
| 2025-12-09 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 553 | $84.53 | $47K |
| 2025-12-09 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 11 | $0.00 | |
| 2025-12-04 | LMAT | LEMAITRE VASCULAR INC | F — Tax withholding / forfeiture | 455 | $83.68 | $38K |
| 2025-12-04 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 45 | $0.00 | |
| 2025-11-21 | LMAT | LEMAITRE VASCULAR INC | M — Option exercise | 2.7K | $41.02 | $110K |
| 2025-09-05 | LMAT | LEMAITRE VASCULAR INC | A — Grant or award | 21.3K | $0.00 |
George W. LeMaitre is the Chairman and CEO of LeMaitre Vascular Inc, a company specializing in medical devices for peripheral vascular disease. He has held various roles within the company, including Director, and has been instrumental in its growth and product development.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($44.98M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LeMaitre George W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.